Literature DB >> 21371252

Effects of lifestyle interventions and long-term weight loss on lipid outcomes - a systematic review.

L Aucott1, D Gray, H Rothnie, M Thapa, C Waweru.   

Abstract

Weight and lipids are critical components of the metabolic syndrome, diabetes and cardiovascular disease. Past reviews considering weight loss on lipid profiles have been for ≤1 year follow-up and/or were for very overweight, obese or morbidly obese participants. This systematic review includes lifestyle interventions for adults (18-65 years), with a mean baseline BMI< 35 kg/m(2) , with weight and lipid differences over 2 years. Between 1990 and 2010, 14 studies were identified. Mean differences for weight and lipids were modest. However, weight loss at 2-3 years follow-up, produced significant beneficial lipid profile changes. These were similar to previous reviews conducted on heavier target groups and/or over shorter follow-up periods; cholesterol (1.3% decrease per kg lost) and triglycerides (1.6% fall per kg). Weight loss sustained longer than 3 years was not associated with beneficial lipid changes, suggesting that other lifestyle changes not just weight loss needs maintaining. Evidence linking lifestyle induced sustained weight loss with lipid profile changes in the long-term for this group is limited. Probable within-group differences (treatment vs prevention), would make further group separation prudent. Individual patient data analysis would facilitate this, uncover baseline, medication and confounding effects, and may identify successful program components enabling more effective obesity prevention and treatment strategies.
© 2011 The Authors. obesity reviews © 2011 International Association for the Study of Obesity.

Entities:  

Mesh:

Year:  2011        PMID: 21371252     DOI: 10.1111/j.1467-789X.2010.00819.x

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  19 in total

Review 1.  Does sustained weight loss reverse the metabolic syndrome?

Authors:  Annie Ferland; Robert H Eckel
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

Review 2.  Diabetes Mellitus and Cardiovascular Disease.

Authors:  Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

3.  The associations between early pregnancy lipid profiles and pregnancy outcomes.

Authors:  C Wang; W Zhu; Y Wei; R Su; H Feng; E Hadar; M Hod; H Yang
Journal:  J Perinatol       Date:  2016-10-27       Impact factor: 2.521

4.  Treatment for overweight and obesity in adult populations: a systematic review and meta-analysis.

Authors:  Leslea Peirson; James Douketis; Donna Ciliska; Donna Fitzpatrick-Lewis; Muhammad Usman Ali; Parminder Raina
Journal:  CMAJ Open       Date:  2014-10-01

5.  Distribution of 10-year and lifetime predicted risk for cardiovascular disease prior to surgery in the longitudinal assessment of bariatric surgery-2 study.

Authors:  Rachel H Mackey; Steven H Belle; Anita P Courcoulas; Greg F Dakin; Clifford W Deveney; David R Flum; Luis Garcia; Wendy C King; Lewis H Kuller; James E Mitchell; Alfons Pomp; Walter J Pories; Bruce M Wolfe
Journal:  Am J Cardiol       Date:  2012-06-27       Impact factor: 2.778

6.  Prediabetes: a prevalent and treatable, but often unrecognized, clinical condition.

Authors:  Joshua D Eikenberg; Brenda M Davy
Journal:  J Acad Nutr Diet       Date:  2013-02       Impact factor: 4.910

Review 7.  Origin and therapy for hypertriglyceridaemia in type 2 diabetes.

Authors:  Jing Pang; Dick C Chan; Gerald F Watts
Journal:  World J Diabetes       Date:  2014-04-15

8.  Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.

Authors:  Edward Gregg; John Jakicic; George Blackburn; Paul Bloomquist; George Bray; Jeanne Clark; Mace Coday; Jeffrey Curtis; Caitlin Egan; Mary Evans; John Foreyt; Gary Foster; Helen Hazuda; James Hill; Edward Horton; Van Hubbard; Robert Jeffery; Karen Johnson; Abbas Kitabchi; William Knowler; Andrea Kriska; Wei Lang; Cora Lewis; Maria Montez; David Nathan; Rebecca Neiberg; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; Bruce Redmon; Judith Regensteiner; Jack Rejeski; Paul Ribisl; Monika Safford; Kerry Stewart; Dace Trence; Thomas Wadden; Rena Wing; Susan Yanovski
Journal:  Lancet Diabetes Endocrinol       Date:  2016-08-30       Impact factor: 32.069

9.  Pre-Conception Dyslipidemia Is Associated with Development of Preeclampsia and Gestational Diabetes Mellitus.

Authors:  Yael Baumfeld; Lena Novack; Arnon Wiznitzer; Eyal Sheiner; Yakov Henkin; Michael Sherf; Victor Novack
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

10.  Type 2 diabetes patients' preferences and willingness to pay for lifestyle programs: a discrete choice experiment.

Authors:  Jorien Veldwijk; Mattijs S Lambooij; Paul F van Gils; Jeroen N Struijs; Henriëtte A Smit; G Ardine de Wit
Journal:  BMC Public Health       Date:  2013-11-29       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.